This study mainly focused on the tumor infiltrating myeloid cells, and revealed the potential mechanism of immunotherapeutics targeting myeloid cells (anti-CSF1R and anti-CD40 agonism) in mouse models with colorectal cancers (32). Here, CD40 is linked to colorectal cancer.